Edris Badreddin

SEC Form 4 insider trading activity

Edris Badreddin has filed 1 SEC Form 4 filing (10 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 23, 2026.

On the most recent filing, Edris Badreddin is listed as Insider at Edgewise Therapeutics, Inc. Inside the rolling window, Edris Badreddin reported no open-market purchases and 1 open-market sale totaling $3.4M in EWTX.

Companies traded

Other insiders at EWTX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EWTX
Edris Badreddin
Sale$3.4MJan 23SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Edris Badreddin made?

Edris Badreddin has filed 1 SEC Form 4 filing (10 transaction rows) across 1 company since 2026.

Which companies does Edris Badreddin trade?

Edris Badreddin has filed SEC Form 4 disclosures for 1 company, including EWTX.

When was Edris Badreddin's most recent SEC Form 4 filing?

Edris Badreddin's most recent SEC Form 4 filing on Tracefour is dated Jan 23, 2026.

What is Edris Badreddin's total buy and sell value in the current window?

Inside the rolling retention window, Edris Badreddin bought $0 and sold $3.4M based on SEC Form 4 filings.

What was Edris Badreddin's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 115,471 EWTX shares on 2026-01-21, worth $3.4M, per SEC Form 4 filings.